Search Results for author: Xiangxiang Zeng

Found 23 papers, 12 papers with code

Leveraging Induced Transferable Binding Principles for Associative Prediction of Novel Drug-Target Interactions

1 code implementation26 Jan 2025 Xiaoqing Lian, Jie Zhu, Tianxu Lv, Shiyun Nie, Hang Fan, Guosheng Wu, Yunjun Ge, Lihua Li, Xiangxiang Zeng, Xiang Pan

Significant differences in protein structures hinder the generalization of existing drug-target interaction (DTI) models, which often rely heavily on pre-learned binding principles or detailed annotations.

Drug Discovery Meta-Learning

Property Enhanced Instruction Tuning for Multi-task Molecule Generation with Large Language Models

1 code implementation24 Dec 2024 Xuan Lin, Long Chen, Yile Wang, Xiangxiang Zeng, Philip S. Yu

In the first step, we use textual descriptions, SMILES, and biochemical properties as multimodal inputs to pre-train a model called PEIT-GEN, by aligning multi-modal representations to synthesize instruction data.

Machine Translation Molecular Property Prediction +3

S$^2$DN: Learning to Denoise Unconvincing Knowledge for Inductive Knowledge Graph Completion

1 code implementation20 Dec 2024 Tengfei Ma, Yujie Chen, Liang Wang, Xuan Lin, Bosheng Song, Xiangxiang Zeng

These results demonstrate the effectiveness of S$^2$DN in preserving semantic consistency and enhancing the robustness of filtering out unreliable interactions in contaminated KGs.

Denoising Inductive knowledge graph completion

Balancing property optimization and constraint satisfaction for constrained multi-property molecular optimization

1 code implementation19 Nov 2024 Xin Xia, YaJie Zhang, Xiangxiang Zeng, Xingyi Zhang, ChunHou Zheng, Yansen Su

Molecular optimization, which aims to discover improved molecules from a vast chemical search space, is a critical step in chemical development.

Y-Mol: A Multiscale Biomedical Knowledge-Guided Large Language Model for Drug Development

no code implementations15 Oct 2024 Tengfei Ma, Xuan Lin, Tianle Li, Chaoyi Li, Long Chen, Peng Zhou, Xibao Cai, Xinyu Yang, Daojian Zeng, Dongsheng Cao, Xiangxiang Zeng

Besides, Y-Mol offers a set of LLM paradigms that can autonomously execute the downstream tasks across the entire process of drug development, including virtual screening, drug design, pharmacological properties prediction, and drug-related interaction prediction.

Drug Design Knowledge Graphs +2

MaskMol: Knowledge-guided Molecular Image Pre-Training Framework for Activity Cliffs

no code implementations2 Sep 2024 Zhixiang Cheng, Hongxin Xiang, Pengsen Ma, Li Zeng, Xin Jin, Xixi Yang, Jianxin Lin, Yang Deng, Bosheng Song, Xinxin Feng, Changhui Deng, Xiangxiang Zeng

Activity cliffs, which refer to pairs of molecules that are structurally similar but show significant differences in their potency, can lead to model representation collapse and make the model challenging to distinguish them.

Drug Discovery Representation Learning +1

MoFormer: Multi-objective Antimicrobial Peptide Generation Based on Conditional Transformer Joint Multi-modal Fusion Descriptor

no code implementations3 Jun 2024 Li Wang, Xiangzheng Fu, Jiahao Yang, Xinyi Zhang, Xiucai Ye, Yiping Liu, Tetsuya Sakurai, Xiangxiang Zeng

Deep learning holds a big promise for optimizing existing peptides with more desirable properties, a critical step towards accelerating new drug discovery.

Drug Discovery

KGExplainer: Towards Exploring Connected Subgraph Explanations for Knowledge Graph Completion

no code implementations5 Apr 2024 Tengfei Ma, Xiang Song, Wen Tao, Mufei Li, Jiani Zhang, Xiaoqin Pan, Jianxin Lin, Bosheng Song, Xiangxiang Zeng

Knowledge graph completion (KGC) aims to alleviate the inherent incompleteness of knowledge graphs (KGs), which is a critical task for various applications, such as recommendations on the web.

Knowledge Graph Embedding

Instruction Multi-Constraint Molecular Generation Using a Teacher-Student Large Language Model

1 code implementation20 Mar 2024 Peng Zhou, Jianmin Wang, Chunyan Li, Zixu Wang, Yiping Liu, Siqi Sun, Jianxin Lin, Leyi Wei, Xibao Cai, Houtim Lai, Wei Liu, Longyue Wang, Yuansheng Liu, Xiangxiang Zeng

While various models and computational tools have been proposed for structure and property analysis of molecules, generating molecules that conform to all desired structures and properties remains a challenge.

Drug Discovery Knowledge Distillation +3

DrugAssist: A Large Language Model for Molecule Optimization

1 code implementation28 Dec 2023 Geyan Ye, Xibao Cai, Houtim Lai, Xing Wang, Junhong Huang, Longyue Wang, Wei Liu, Xiangxiang Zeng

Recently, the impressive performance of large language models (LLMs) on a wide range of tasks has attracted an increasing number of attempts to apply LLMs in drug discovery.

Drug Discovery Language Modeling +3

DiffColor: Toward High Fidelity Text-Guided Image Colorization with Diffusion Models

no code implementations3 Aug 2023 Jianxin Lin, Peng Xiao, Yijun Wang, Rongju Zhang, Xiangxiang Zeng

To address these issues, we propose a new method called DiffColor that leverages the power of pre-trained diffusion models to recover vivid colors conditioned on a prompt text, without any additional inputs.

Colorization Image Colorization +1

Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction

1 code implementation8 Jun 2023 Xuan Lin, Lichang Dai, Yafang Zhou, Zu-Guo Yu, Wen Zhang, Jian-Yu Shi, Dong-Sheng Cao, Li Zeng, Haowen Chen, Bosheng Song, Philip S. Yu, Xiangxiang Zeng

Recent advances and achievements of artificial intelligence (AI) as well as deep and graph learning models have established their usefulness in biomedical applications, especially in drug-drug interactions (DDIs).

Drug Discovery Graph Learning +2

LRBmat: A Novel Gut Microbial Interaction and Individual Heterogeneity Inference Method for Colorectal Cancer

1 code implementation13 Mar 2023 Shan Tang, Shanjun Mao, Yangyang Chen, Falong Tan, Lihua Duan, Cong Pian, Xiangxiang Zeng

Many methods adopt gut microbiota to solve it, but few of them simultaneously take into account the complex interactions and individual heterogeneity of gut microbiota, which are two common and important issues in genetics and intestinal microbiology, especially in high-dimensional cases.

Diagnostic

Molecule optimization via multi-objective evolutionary in implicit chemical space

no code implementations17 Dec 2022 Xin Xia, Yansen Su, ChunHou Zheng, Xiangxiang Zeng

However, efficient search for optimized molecules satisfying several properties with scarce labeled data remains a challenge for machine learning molecule optimization.

Multi-View Substructure Learning for Drug-Drug Interaction Prediction

no code implementations28 Mar 2022 Zimeng Li, Shichao Zhu, Bin Shao, Tie-Yan Liu, Xiangxiang Zeng, Tong Wang

Drug-drug interaction (DDI) prediction provides a drug combination strategy for systemically effective treatment.

Prediction

Heterogeneous network-based drug repurposing for COVID-19

1 code implementation20 Jul 2021 Shuting Jin, Xiangxiang Zeng, Wei Huang, Feng Xia, Changzhi Jiang, Xiangrong Liu, Shaoliang Peng

The Corona Virus Disease 2019 (COVID-19) belongs to human coronaviruses (HCoVs), which spreads rapidly around the world.

Repurpose Open Data to Discover Therapeutics for COVID-19 using Deep Learning

no code implementations21 May 2020 Xiangxiang Zeng, Xiang Song, Tengfei Ma, Xiaoqin Pan, Yadi Zhou, Yuan Hou, Zheng Zhang, George Karypis, Feixiong Cheng

While this study, by no means recommends specific drugs, it demonstrates a powerful deep learning methodology to prioritize existing drugs for further investigation, which holds the potential of accelerating therapeutic development for COVID-19.

Cannot find the paper you are looking for? You can Submit a new open access paper.